Stock Spotlight

Stock Spotlight: The a2 Milk Co Ltd (ASX:A2M)

Stock Spotlight: The a2 Milk Co Ltd (ASX:A2M)

Key stats

$4.75B
Market cap
$6.70
Share price
-17.38%
1 year return
P/E ratio
3.16%
Dividend yield
0.29
Beta
$0.26
EPS
1.75
PEG ratio
Short interest
Consumer Defensive
Industry

Source: EODHD. Data as of 06/05/26.

About The a2 Milk Co Ltd

The a2 Milk Company Limited, together with its subsidiaries, sells A2-type protein type branded milk and related products in Australia, New Zealand, China, rest of Asia, and the United States. The company offers infant milk formula; other nutritional products and milk; manufactures and sells nutritional and ingredients products, as well as provides rent, royalty, and licensing services. It offers its products under the a2 Milk and a2 Platinum brands. The company was formerly known as A2 Corporation Limited and changed its name to The a2 Milk Company Limited in April 2014. The a2 Milk Company Limited was incorporated in 2000 and is based in Auckland, New Zealand.

Source: EODHD

Price Performance

Growth Potential

  • Subject to supply chain normalisation and no further adverse update with respect to current product recall, demand in China remains solid and we see material upside from current share price levels.
  • Potential to win further market share in Australia and China. Growing consumer demand for health and well-being globally.
  • Demand growth in China for ultra-premium infant formula products. YNZ acquisition will allow A2M to increase its CL products.
  • New product development – A2M has accelerated innovation with the Company launching new products in IMF and other nutritional categories targeting infants, kids and senior segments.
  • Key patents provide a barrier to entry.
  • Capital management – dividend policy plus potential for special dividends (cash on balance sheet above $1bn with little debt).

Key Risks

  • Further supply chain disruptions due to tensions in the Middle East.
  • Product recall spreads to other regions after further testing.
  • Execution risk – especially with the recent supply chain investment.
  • Management fails to meet their $2bn sales guidance.
  • Chinese demand underperforms market expectations.
  • Disruption to A2 milk supply.
  • Increased competition, including private labels & competitors developing products or branding that erode the differentiation of A2M branded products from other dairy products.

Frequently asked questions

This article is general information only and does not take into account your objectives, financial situation or needs. It is not a recommendation to buy or sell any security. Past performance is not a reliable indicator of future performance. Consider seeking financial, legal and taxation advice before investing.

Newsletter

Get our insights in your inbox

Join the Sharewise newsletter for new market insights and stock spotlights, plus invites to company webinars and Stocks and Sips evenings.

More articles

All news →

Want more than one article's worth?

Sharewise clients get ongoing research, Advisor access and execution across ASX, US and global markets.

Explore our services →